Cargando…
What’s new in melanoma? Combination!
Melanoma was again a focus of attention at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, in particular the use of combination treatment strategies involving immunotherapies and/or targeted agents. New data on targeted therapies confirmed previous findings, with combined BRAF...
Autores principales: | Ascierto, Paolo A, Marincola, Francesco M, Atkins, Michael B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491255/ https://www.ncbi.nlm.nih.gov/pubmed/26141621 http://dx.doi.org/10.1186/s12967-015-0582-1 |
Ejemplares similares
-
Melanoma: From Research to Treatment
por: Ascierto, Paolo A., et al.
Publicado: (2011) -
Combination therapy: the next opportunity and challenge of medicine
por: Ascierto, Paolo A, et al.
Publicado: (2011) -
What is changing in the adjuvant treatment of melanoma?
por: Ascierto, Paolo A., et al.
Publicado: (2017) -
Melanoma: the role of surgery in the era of new therapies
por: Mozzillo, Nicola, et al.
Publicado: (2014) -
2015: The Year of Anti-PD-1/PD-L1s Against Melanoma and Beyond
por: Ascierto, Paolo A., et al.
Publicado: (2015)